Imcyse
PrivateLast Round
Series B
Extension
Feb 17, 2021
Total Funding Raised
$66.18M
Company Overview
ImCyse is a biotechnology company specializing in therapeutic vaccines aimed at treating multiple sclerosis and diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
specific immunotherapyautoimmune disease therapyImotope platformpeptide therapyT-cell therapytargeted immunotherapycytolytic T-cellsType 1 Diabetes therapyMultiple Sclerosis therapypharmaceutical licensingdrug developmentprecision medicinemodified peptidescell therapyclinical-stage biotechRheumatoid Arthritis therapy
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imcyse Comps
Public and private peers based on sector, stage, and business model.
Imcyse Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 17, 2021 | ||||
| Grant | Jul 28, 2020 | ||||
| Debt | Jun 18, 2019 | ||||
| Series B | Jun 18, 2019 | ||||
| Grant | Jun 18, 2019 |
Imcyse Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series B Extension, Series B |
| EQT Life Sciences | Series B |
| Noshaq | Series B Extension, Series B |
| Epimede | Series B Extension, Series B |
| Société Régionale d'Investissement de Wallonie | Series B Extension, Series B |
| KU Leuven | Series B Extension, Series B |
| Pfizer | Series B Extension |
Imcyse Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Imcyse's valuation, stock price, and market status.
Firmographic Details
HeadquartersWallonia
Employee Range6
Year Founded2010
Last FundingFeb 17, 2021
